USCB vs CARE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 16, 2026
USCB
CARE
Investment Advisor Scores
CARE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | USCB | CARE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 11.4548 | 13.6612 | USCB |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 14.1% | 68.3% | CARE |
| Earnings Growth | 22.5% | 253.9% | CARE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 42.7/100 | 61.6/100 | CARE |
| Profit Margin | 30.4% | 44.9% | CARE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
USCB
MarkupPrice above SMA50, rising 50-day trend (5.6% over 20 days), RSI 61
CARE
MarkdownPrice below a falling SMA50 (slope -0.7%), weak momentum, RSI 41
Fundamentals Snapshot
| Metric | USCB | CARE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.9 | 11.7 |
| Trailing P/E | 14.8 | 5.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.7% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.5% | 0.6% |
| EPS | 1.55 | 5.70 |
| Dividend Yield | 0.02% | 0.00% |